-
Antibodies, Research Grade BiosimilarsEpratuzumab Biosimilar, Endotoxin 0.05 EU/mg | C046P.05
$750.00 – $3,000.00Epratuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Epratuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg | C040P.05
$900.00 – $2,400.00Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg | C069P.05
$900.00 – $2,400.00Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Brolucizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Ipilimumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C050P.LA
$650.00Ipilimumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. The research grade Ipilimumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Ipilimumab Biosimilar, Human IgG4 S228P Mutant | C050P.NA
$650.00Ipilimumab Biosimilar, N297A Mutant. The research grade Ipilimumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Obinutuzumab Biosimilar, Endotoxin 0.05 EU/mg | C057P.05
$900.00 – $1,800.00Obinutuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Obinutuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Omalizumab Biosimilar, N297A Mutant | C020P.NA
$650.00Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C020P.LA
$650.00Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Palivizumab Biosimilar, N297A Mutant | C021P.NA
$650.00Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C021P.LA
$650.00Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05
$720.00 – $1,440.00Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for…
Select optionsQuick View - Antibodies, Research Grade Biosimilars
Panitumumab Biosimilar, N297A Mutant | C012P.NA
$650.00Panitumumab Biosimilar, N297A Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research…
Select optionsQuick View
